• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Gold Gains 1%; US Consumer Sentiment Falls In June

    6/14/24 12:03:10 PM ET
    $FOXO
    $GANX
    $INAB
    $IRON
    Life Insurance
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $FOXO alert in real time by email

    U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 200 points on Friday.

    The Dow traded down 0.63% to 38,403.11 while the NASDAQ fell 0.07% to 17,655.10. The S&P 500 also fell, dropping, 0.37% to 5,413.41  .

    Check This Out: Top 2 Materials Stocks That May Collapse This Quarter

    Leading and Lagging Sectors

    Communication services shares jumped by 0.4% on Friday.

    In trading on Friday, industrials shares fell by 2.1%.

    Top Headline

    The University of Michigan consumer sentiment declined for a third consecutive month to a reading of 65.6 in June, notching the lowest level since November, compared to 69.1 in May and down from market estimates of 72.

    Equities Trading UP
                           

    • Disc Medicine, Inc. (NASDAQ:IRON) shares shot up 20% to $46.85. Disc Medicine announced a $178 million underwritten offering of 4.944 million shares at $36 per share.
    • Shares of SRIVARU Holding Limited (NASDAQ:SVMH) got a boost, surging 120% to $0.3364 after the company announced it will begin accepting paid reservations and bookings for its flagship product, the PRANA 2.0, on June 16th.
    • FOXO Technologies Inc. (NASDAQ:FOXO) shares were also up, gaining 16% to $0.2763 after the company announced it entered into share exchange agreements with Rennova Health.

    Equities Trading DOWN

    • QXO, Inc. (NASDAQ:QXO) shares dropped 32% to $140.00 after announcing a $3.5 billion private placement.
    • Shares of IN8bio, Inc. (NASDAQ:INAB) were down 30% to $1.1701 after the company presented data from its Phase 1 trial of INB-100 showing 100% of treated leukemia patients achieved durable complete remission at 1 year.
    • Gain Therapeutics, Inc. (NASDAQ:GANX) was down, falling 33% to $1.27 after the company announced the pricing of a $11 million public offering of 7,116,547 shares at $1.35 per share and pre-funded warrants.

    Also Check This Out: How To Earn $500 A Month From KB Home Stock Ahead Of Q2 Earnings

    Commodities

    In commodity news, oil traded up 0.1% to $78.66 while gold traded up 1.1% at $2,344.50.

    Silver traded up 0.4% to $29.17 on Friday, while copper fell 0.3% to $4.4685.

    Euro zone

    European shares were lower today. The eurozone's STOXX 600 fell 1.23%, Germany's DAX dipped 1.68% and France's CAC 40 tumbled 3.11%. Spain's IBEX 35 Index fell 1.38%, while London's FTSE 100 slipped 0.40%.

    The Eurozone recorded a trade surplus of EUR 15 billion in April versus a year-ago gap of EUR 11.1 billion. The annual inflation rate in France accelerated to 2.3% in May from 2.2% in April.

    Asia Pacific Markets

    Asian markets closed mostly higher on Friday, with Japan's Nikkei gaining 0.24%, Hong Kong's Hang Seng Index declining 0.94%, China's Shanghai Composite Index gaining 0.12% and India's S&P BSE Sensex gaining 0.24%.

    Indian merchandise trade deficit widened to a seven-month of $23.8 billion in May, while wholesale prices increased by 2.61% year-over-year in May. Manufacturing production in Hong Kong increased 1.8% year-over-year in the first quarter versus a 4.1% rise in the prior period. Chinese vehicle sales gained by 1.5% year-over-year to 2.42 million in May.

    Industrial production in Japan fell 0.9% month-over-month in April. The Bank of Japan held its key short-term interest rate at about 0% to 0.1% at its recent meeting.

    Economics

    • Import prices in the U.S. declined by 0.4% month-over-month in May.
    • U.S. export prices declined by 0.6% month-over-month in May compared to a revised 0.6% gain in the prior month.
    • The University of Michigan consumer sentiment declined for a third consecutive month to a reading of 65.6 in June, notching the lowest level since November, compared to 69.1 in May and down from market estimates of 72.

    Now Read This: Hasbro To Rally Around 38%? Here Are 10 Top Analyst Forecasts For Friday

    Get the next $FOXO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FOXO
    $GANX
    $INAB
    $IRON

    CompanyDatePrice TargetRatingAnalyst
    QXO Inc.
    $QXO
    12/12/2025$31.00Buy
    Loop Capital
    Disc Medicine Inc.
    $IRON
    11/3/2025$125.00Buy
    Stifel
    QXO Inc.
    $QXO
    10/21/2025$30.00Buy
    Vertical Research
    QXO Inc.
    $QXO
    10/1/2025$28.00Overweight
    KeyBanc Capital Markets
    QXO Inc.
    $QXO
    9/5/2025$28.00Outperform
    Raymond James
    QXO Inc.
    $QXO
    9/2/2025$35.00Overweight
    Morgan Stanley
    QXO Inc.
    $QXO
    8/22/2025$50.00Buy
    The Benchmark Company
    QXO Inc.
    $QXO
    8/13/2025$29.00Overweight
    Stephens
    More analyst ratings

    $FOXO
    $GANX
    $INAB
    $IRON
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Loop Capital initiated coverage on QXO, Inc with a new price target

    Loop Capital initiated coverage of QXO, Inc with a rating of Buy and set a new price target of $31.00

    12/12/25 8:55:06 AM ET
    $QXO
    RETAIL: Building Materials
    Consumer Discretionary

    Stifel resumed coverage on Disc Medicine with a new price target

    Stifel resumed coverage of Disc Medicine with a rating of Buy and set a new price target of $125.00

    11/3/25 9:08:29 AM ET
    $IRON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Vertical Research initiated coverage on QXO, Inc with a new price target

    Vertical Research initiated coverage of QXO, Inc with a rating of Buy and set a new price target of $30.00

    10/21/25 7:21:53 AM ET
    $QXO
    RETAIL: Building Materials
    Consumer Discretionary

    $FOXO
    $GANX
    $INAB
    $IRON
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    QXO to Buy Kodiak Building Partners for $2.25 Billion

    Expected to Be Highly Accretive to QXO's Earnings in 2026 QXO, Inc. (NYSE:QXO) today announced it has entered into a definitive agreement to acquire Kodiak Building Partners ("Kodiak") from Court Square Capital Partners for approximately $2.25 billion. The transaction is expected to be highly accretive to 2026 earnings and will expand QXO's current addressable market to more than $200 billion. The purchase price comprises $2.0 billion of cash and 13.2 million shares, with QXO retaining the right to repurchase these shares at $40 per share. The transaction is expected to close early in the second quarter of 2026, subject to the satisfaction of customary closing conditions. Kodiak gener

    2/11/26 6:00:00 AM ET
    $QXO
    RETAIL: Building Materials
    Consumer Discretionary

    IN8bio Promotes Kate Rochlin, Ph.D., to President and Chief Operating Officer

    NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) -- IN8bio (NASDAQ:INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ ) T cell therapies and T cell engagers for cancer and autoimmune diseases, today announced the promotion of Kate Rochlin, Ph.D., to President and Chief Operating Officer, effective immediately. Dr. Rochlin has served as IN8bio's Chief Operating Officer since December 2021, following her tenure as Vice President and Associate Vice President of Operations and Innovation beginning in August 2020. In her expanded role, she will continue to oversee company operations as IN8bio advances its clinical and preclinical pipeline and prepares for its next

    2/9/26 8:00:00 AM ET
    $INAB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    IN8bio to Present at Upcoming Investor and Scientific Conferences in February

    NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- IN8bio, Inc. (NASDAQ:INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ ) T cell therapies for cancer and autoimmune diseases, today announced that William Ho, CEO and co-founder, will be presenting the following investor and scientific conferences in February. Conference participation details are as follows: Noble Emerging Growth Virtual Equity ConferenceDate: Thursday, February 5, 2026Time: 3:00 p.m. ETLocation: Virtual Investor Registration IO360° ConferenceDate: Thursday, February 12, 2026Time: 1:20 p.m. – 1:40 p.m. ETSession: IO Clinical Advancements Plenary Presentation title: IN8bio's Unique DeltEx D

    2/3/26 8:00:00 AM ET
    $INAB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $FOXO
    $GANX
    $INAB
    $IRON
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer Khara Rahul was granted 17,000 shares, increasing direct ownership by 45% to 55,026 units (SEC Form 4)

    4 - Disc Medicine, Inc. (0001816736) (Issuer)

    2/11/26 7:50:27 PM ET
    $IRON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Commercial Officer Stephenson Pamela was granted 17,000 shares, increasing direct ownership by 24% to 86,529 units (SEC Form 4)

    4 - Disc Medicine, Inc. (0001816736) (Issuer)

    2/11/26 7:46:22 PM ET
    $IRON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Medical Officer Savage William Jacob was granted 17,000 shares, increasing direct ownership by 22% to 95,845 units (SEC Form 4)

    4 - Disc Medicine, Inc. (0001816736) (Issuer)

    2/11/26 7:40:31 PM ET
    $IRON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FOXO
    $GANX
    $INAB
    $IRON
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CFO and Interim CEO Mack Gene bought $14,544 worth of shares (14,400 units at $1.01) (SEC Form 4)

    4 - Gain Therapeutics, Inc. (0001819411) (Issuer)

    8/12/24 5:23:31 PM ET
    $GANX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Executive Chairman Islam Khalid bought $49,940 worth of shares (50,000 units at $1.00) (SEC Form 4)

    4 - Gain Therapeutics, Inc. (0001819411) (Issuer)

    8/12/24 5:23:30 PM ET
    $GANX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Richman Eric I bought $20,670 worth of shares (17,000 units at $1.22), increasing direct ownership by 6% to 289,629 units (SEC Form 4)

    4 - Gain Therapeutics, Inc. (0001819411) (Issuer)

    7/1/24 5:00:27 PM ET
    $GANX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FOXO
    $GANX
    $INAB
    $IRON
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by QXO Inc.

    SCHEDULE 13G/A - QXO, Inc. (0001236275) (Subject)

    2/12/26 2:17:56 PM ET
    $QXO
    RETAIL: Building Materials
    Consumer Discretionary

    SEC Form EFFECT filed by FOXO Technologies Inc.

    EFFECT - FOXO TECHNOLOGIES INC. (0001812360) (Filer)

    2/12/26 12:15:28 AM ET
    $FOXO
    Life Insurance
    Finance

    SEC Form 424B3 filed by FOXO Technologies Inc.

    424B3 - FOXO TECHNOLOGIES INC. (0001812360) (Filer)

    2/11/26 4:23:26 PM ET
    $FOXO
    Life Insurance
    Finance

    $FOXO
    $GANX
    $INAB
    $IRON
    Leadership Updates

    Live Leadership Updates

    View All

    Disc Medicine Appoints Lisa Amaya Price, MBA as Chief Human Resources Officer

    WATERTOWN, Mass., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced the appointment of Lisa Amaya Price, MBA as the company's Chief Human Resources (HR) Officer. Ms. Amaya Price brings more than 25 years of experience in human resources and organizational leadership, including at multiple commercial-stage companies. "As we move towards commercialization, we have meaningfully increased hiring to support these efforts and Lisa will play a central role in building a strong, scal

    1/12/26 4:30:00 PM ET
    $IRON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FOXO TECHNOLOGIES INC.'S BIG SOUTH FORK MEDICAL CENTER COMPLETES PERFORMANCE NETWORK AGREEMENT WITH COVENANT HEALTH TO PROVIDE SWING BED SERVICES

    WEST PALM BEACH, FLORIDA, Aug. 01, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE:FOXO) ("FOXO" or the "Company") today announced that its critical access designated rural hospital, Big South Fork Medical Center located in Oneida, Tennessee, has completed a Performance Network Agreement with Covenant Health to join their performance network as a provider of swing bed services. Covenant Health is a large, muti-facility hospital network serving greater Knoxville and East Tennessee. Patients who no longer meet acute care admission criteria are frequently in need of post-acute care to enhance their recovery. Big South Fork Medical Center is well positioned to provide swing bed services

    8/1/25 7:52:00 AM ET
    $FOXO
    Life Insurance
    Finance

    QXO Appoints Michael DeWitt as Chief Procurement Officer

    QXO, Inc. (NYSE:QXO) today announced that Michael DeWitt has been appointed chief procurement officer, effective immediately. DeWitt will lead the company's procurement transformation as QXO scales to become the tech-enabled leader in the $800 billion building products distribution industry. DeWitt joins QXO after eight years as vice president of international spend management at Walmart International, where he was responsible for $10 billion of purchasing and digital transformation across 18 countries. He brings nearly three decades of experience in procurement innovation across multiple industries and continents. Brad Jacobs, chairman and chief executive officer of QXO, said, "Michael

    7/21/25 8:00:00 AM ET
    $QXO
    RETAIL: Building Materials
    Consumer Discretionary

    $FOXO
    $GANX
    $INAB
    $IRON
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Disc Medicine Inc.

    SC 13G/A - Disc Medicine, Inc. (0001816736) (Subject)

    11/14/24 5:44:55 PM ET
    $IRON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Disc Medicine Inc.

    SC 13G/A - Disc Medicine, Inc. (0001816736) (Subject)

    11/14/24 4:33:10 PM ET
    $IRON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by QXO Inc.

    SC 13G - QXO, Inc. (0001236275) (Subject)

    11/13/24 9:11:27 AM ET
    $QXO
    RETAIL: Building Materials
    Consumer Discretionary

    $FOXO
    $GANX
    $INAB
    $IRON
    Financials

    Live finance-specific insights

    View All

    QXO Announces Fourth Quarter Summarized Preliminary Financial Information

    QXO, Inc. ("QXO" or the "Company") (NYSE:QXO) today announced the following summarized preliminary financial information. The Company expects to file its annual report on Form 10-K for the year ended December 31, 2025 on February 26, 2026. FOURTH QUARTER 2025 SUMMARY PRELIMINARY RESULTS Net sales of approximately $2.19 billion Adjusted EBITDA of approximately $150 million The Company's preliminary unaudited financial results in this press release for the fourth quarter ended December 31, 2025 are preliminary, unaudited and subject to completion, and may change as a result of management's continued review. Such preliminary results are subject to the finalization of quarter-end fin

    1/15/26 5:06:00 PM ET
    $QXO
    RETAIL: Building Materials
    Consumer Discretionary

    FOXO TECHNOLOGIES INC. CEO SEAMUS LAGAN PROVIDES YEAR-END REVIEW TO SHAREHOLDERS

    WEST PALM BEACH, FL, Dec. 15, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (OTC:FOXO) (the "Company"), announces Chief Executive Officer Seamus Lagan has provided the following Year-End Review to shareholders: FOXO Shareholders: As we rapidly approach year-end, I wanted to reach out to our shareholders to review key milestones of 2025 and preview our go-forward operating and growth strategy. Much of the foundation of the "new" FOXO was created in mid-2024 when the Company acquired both Myrtle Recovery Centers, Inc. and Rennova Community Health, Inc. (including its principal subsidiary, Scott County Community Hospital, Inc.). More recently, we expanded our portfolio of healthcare-relat

    12/15/25 8:07:00 AM ET
    $FOXO
    Life Insurance
    Finance

    QXO Reports Third Quarter 2025 Results

    QXO, Inc. ("QXO" or the "Company") (NYSE:QXO) today issued its financial results for the third quarter 2025, in line with the preliminary third-quarter information provided during last week's term loan refinancing. The Company reported a basic and diluted loss per common share of $(0.24) and an Adjusted Diluted Earnings per Common Share ("Adjusted Diluted EPS"), a non-GAAP financial measure, of $0.14 for the three months ended September 30, 2025. THIRD QUARTER 2025 SUMMARY RESULTS     Three Months Ended September 30, (in millions, except for per share data) 2025   2024 Net sales $ 2,728.3     $ 13.1   Gross profit $ 635.8  

    11/6/25 4:05:00 PM ET
    $QXO
    RETAIL: Building Materials
    Consumer Discretionary